Drug intelligence / Profile preview

oral sulphate tablet

Development stage: Unknown
Lead developer: Braintree Laboratories
Modality: Small Molecules
Administration: Oral

Overview

Oral sulphate tablet (OST) is a novel pharmaceutical formulation used for bowel preparation in patients, particularly those with inflammatory bowel disease (IBD). It functions as an osmotic laxative, drawing water into the bowel lumen to facilitate cleansing. Clinical studies have demonstrated its efficacy, safety, and tolerability as a bowel preparation agent, showing comparable cleansing success rates to polyethylene glycol and ascorbate (PEG/Asc) while offering advantages in terms of ease of ingestion and taste. It has been studied in a split-dose regimen for colonoscopy preparation.

Beyond the preview

Go deeper on oral sulphate tablet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on oral sulphate tablet.

Explore the full profile